Cardiovascular Pharmacology and Drug Development

Cardiovascular pharmacology and drug development have seen significant progress, introducing new therapies that enhance treatment options for heart diseases. Recent advancements include PCSK9 inhibitors like alirocumab and evolocumab, which markedly lower LDL cholesterol levels and reduce cardiovascular events. SGLT2 inhibitors, such as empagliflozin and canagliflozin, originally used for diabetes, have demonstrated substantial benefits in heart failure management. ARNi (sacubitril/valsartan) represents a breakthrough in heart failure treatment by combining neprilysin inhibition with angiotensin receptor blockade, improving cardiac function and reducing hospitalizations. Novel anti-fibrotic and anti-inflammatory agents are being explored to target underlying disease mechanisms, potentially slowing or reversing heart damage. Advances in drug delivery systems, including extended-release formulations and targeted therapies, aim to optimize drug efficacy and minimize side effects. These innovations in pharmacology and drug development are enhancing the management of cardiovascular conditions, leading to better patient outcomes and quality of life.

    Related Conference of Cardiovascular Pharmacology and Drug Development

    August 11-12, 2025

    3rd International Conference on World Heart Care

    Toronto, Canada
    August 19-20, 2025

    29th World Cardiology Conference

    Paris, France
    August 21-22, 2025

    8th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada
    September 08-09, 2025

    39th European Cardiology Conference

    Frankfurt, Germany
    September 22-23, 2025

    14th World Heart Congress

    Dubai, UAE
    September 22-23, 2025

    7th Annual Conference on Vascular Medicine

    Amsterdam, Netherlands
    September 22-23, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Tokyo, Japan
    September 25-26, 2025

    13th International Conference on Hypertension and Healthcare

    Zurich, Switzerland
    October 20-21, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Aix-en-Provence, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France

    Cardiovascular Pharmacology and Drug Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in